Answers are grounded in this paper and cite their sources.
Gold nanoparticles are emerging as promising agents for cancer therapy and are being investigated as drug carriers, photothermal agents, contrast agents and radiosensitisers. This review introduces the field of nanotechnology with a focus on recent gold nanoparticle research which has led to early-phase clinical trials. In particular, the pre-clinical evidence for gold nanoparticles as sensitisers with ionising radiation in vitro and in vivo at kilovoltage and megavoltage energies is discussed.
No takes yet. Share an insight, caveat, or question.
Jain et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: